Announced appointment of Steven Egge as Chief Commercial Officer in July 2024. Mr. Egge has broad commercial and therapeutic area experience, including in HPV-related diseases and cancers, vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback